[1]
|
Torre, L.A., Bray, F., Siegel, R.L., et al. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. https://doi.org/10.3322/caac.21262
|
[2]
|
Wang, W. and Wei, C. (2020) Advances in the Early Diagnosis of Hepatocellular Carcinoma. Genes & Diseases, 7, 308-319. https://doi.org/10.1016/j.gendis.2020.01.014
|
[3]
|
Benson, A.B., D’Angelica, M.I., Abrams, T.A., et al. (2014) Hepatobiliary Cancers, Version 2.2014. Journal of the National Comprehensive Cancer Network, 12, 1152-1182. https://doi.org/10.6004/jnccn.2014.0112
|
[4]
|
Heimbach, J.K., Kulik, L.M., Finn, R.S., et al. (2018) AASLD Guidelines for the Treatment of Hepatocellular Carcinoma. Hepatology, 67, 358-380. https://doi.org/10.1002/hep.29086
|
[5]
|
吴孟超, 汤钊猷, 刘彤华, 等. 原发性肝癌规范化病理诊断指南(2015年版) [J]. 临床肝胆病杂志, 2015, 31(6): 833-839.
|
[6]
|
Wang, W., Guo, Y., Zhong, J., et al. (2021) The Clinical Significance of Microvascular Invasion in the Surgical Planning and Postoperative Sequential Treatment in Hepatocellular Carcinoma. Scientific Reports, 11, Article No. 2415. https://doi.org/10.1038/s41598-021-82058-x
|
[7]
|
Bruix, J., Reig, M. and Sherman, M. (2016) Evidence-Based Diagnosis, Staging, and Treatment of Patients with Hepatocellular Carcinoma. Gastroenterology, 150, 835-853. https://doi.org/10.1053/j.gastro.2015.12.041
|
[8]
|
Ishizawa, T., Hasegawa, K., Aoki, T., et al. (2008) Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma. Gastroenterology, 134, 1908-1916. https://doi.org/10.1053/j.gastro.2008.02.091
|
[9]
|
Hou, Y.F., Wei, Y.G., Yang, J.Y., et al. (2016) Microvascular Invasion Patterns Affect Survival in Hepatocellular Carcinoma Patients after Second Hepatectomy. The Journal of Surgical Research, 200, 82-90. https://doi.org/10.1016/j.jss.2015.06.069
|
[10]
|
Erstad, D.J. and Tanabe, K.K. (2019) Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. Annals of Surgical Oncology, 26, 1474-1493. https://doi.org/10.1245/s10434-019-07227-9
|
[11]
|
Imamura, H., Matsuyama, Y., Tanaka, E., et al. (2003) Risk Factors Contributing to Early and Late Phase Intrahepatic Recurrence of Hepatocellular Carcinoma after Hepatectomy. Journal of Hepatology, 38, 200-207. https://doi.org/10.1016/S0168-8278(02)00360-4
|
[12]
|
Wang, M.D., Li, C., Liang, L., et al. (2020) Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma. The Oncologist, 25, e1541-e1551. https://doi.org/10.1634/theoncologist.2019-0944
|
[13]
|
Gouw, A.S.H., Balabaud, C., Kusano, H., et al. (2011) Markers for Microvascular Invasion in Hepatocellular Carcinoma: Where Do We Stand? Liver Transplantation, 17, S72-S80. https://doi.org/10.1002/lt.22368
|
[14]
|
Zhang, X.P., Wang, K., Wei, X.B., et al. (2019) An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion after R0 Liver Resection: A Large-Scale, Multicenter Study. The Oncologist, 24, e1476-e1488. https://doi.org/10.1634/theoncologist.2018-0868
|
[15]
|
Budhu, A., Forgues, M., Ye, Q.H., et al. (2006) Prediction of Venous Metastases, Recurrence, and Prognosis in Hepatocellular Carcinoma Based on a Unique Immune Response Signature of the Liver Microenvironment. Cancer Cell, 10, 99-111. https://doi.org/10.1016/j.ccr.2006.06.016
|
[16]
|
Cong, W.M., Bu, H., Chen, J., et al. (2016) Practice Guidelines for the Pathological Diagnosis of Primary Liver Cancer: 2015 Update. World Journal of Gastroenterology, 22, 9279-9287. https://doi.org/10.3748/wjg.v22.i42.9279
|
[17]
|
Yang, L., Gu, D., Wei, J., et al. (2019) A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Liver Cancer, 8, 373-386. https://doi.org/10.1159/000494099
|
[18]
|
Psaila, B. and Lyden, D. (2009) The Metastatic Niche: Adapting the Foreign Soil. Nature Reviews Cancer, 9, 285-293. https://doi.org/10.1038/nrc2621
|
[19]
|
Pawlik, T.M., Delman, K.A., Vauthey, J.N., et al. (2005) Tumor Size Predicts Vascular Invasion and Histologic Grade: Implications for Selection of Surgical Treatment for Hepatocellular Carcinoma. Liver Transplantation, 11, 1086-1092. https://doi.org/10.1002/lt.20472
|
[20]
|
周小泉, 赵凯亮, 王卫星. 肝细胞癌微血管侵犯术前预测因素及价值探讨[J]. 微循环学杂志, 2023, 33(2): 55-60.
|
[21]
|
Song, D.S. and Bae, S.H. (2012) Changes of Guidelines Diagnosing Hepatocellular Carcinoma during the Last Ten-Year Period. Clinical and Molecular Hepatology, 18, 258-267. https://doi.org/10.3350/cmh.2012.18.3.258
|
[22]
|
Jiang, J.T., Wu, C.P., Xu, N.,et al. (2009) Clinical Evaluation of Serum α-Fetoprotein-IgM Immune Complexes on the Diagnosis of Primary Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis, 23, 213-218. https://doi.org/10.1002/jcla.20321
|
[23]
|
Omata, M., Lesmana, L.A., Tateishi, R., et al. (2010) Asian Pacific Association for the Study of the Liver Consensus Recommendations on Hepatocellular Carcinoma. Hepatology International, 4, 439-474. https://doi.org/10.1007/s12072-010-9165-7
|
[24]
|
Parikh, N.D., Mehta, A.S., Singal, A.G., et al. (2020) Biomarkers for the Early Detection of Hepatocellular Carcinoma. Cancer Epidemiology. Biomarkers & Prevention, 29, 2495-2503. https://doi.org/10.1158/1055-9965.EPI-20-0005
|
[25]
|
Nanashima, A., Abo, T., Taura, N., et al. (2013) NX-PVKA Levels before and after Hepatectomy of Hepatocellular Carcinoma as Predictors of Patient Survival: A Preliminary Evaluation of an Improved Assay for PIVKA-II. Anticancer Research, 33, 2689-2697.
|
[26]
|
Liebman, H.A., Furie, B.C., Tong, M.J., et al. (1984) Des-Gamma-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma. The New England Journal of Medicine, 310, 1427-1431. https://doi.org/10.1056/NEJM198405313102204
|
[27]
|
Imamura, H., Matsuyama, Y., Miyagawa, Y., et al. (1999) Prognostic Significance of Anatomical Resection and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma. The British Journal of Surgery, 86, 1032-1038. https://doi.org/10.1046/j.1365-2168.1999.01185.x
|
[28]
|
Koike, Y., Shiratori, Y., Sato, S., et al. (2001) Des-Gamma-Carboxy Prothrombin as a Useful Predisposing Factor for the Development of Portal Venous Invasion in Patients with Hepatocellular Carcinoma: A Prospective Analysis of 227 Patients. Cancer, 91, 561-569. https://doi.org/10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N
|
[29]
|
Poté, N., Cauchy, F., Albuquerque, M., et al. (2015) Performance of PIVKA-II for Early Hepatocellular Carcinoma Diagnosis and Prediction of Microvascular Invasion. Journal of Hepatology, 62, 848-854. https://doi.org/10.1016/j.jhep.2014.11.005
|
[30]
|
Aoyagi, Y., Isemura, M., Suzuki, Y., et al. (1985) Fucosylated Alpha-Fetoprotein as Marker of Early Hepatocellular Carcinoma. Lancet, 2, 1353-1354. https://doi.org/10.1016/S0140-6736(85)92643-1
|
[31]
|
Kumada, T., Nakano, S., Takeda, I., et al. (1999) Clinical Utility of Lens Culinaris Agglutinin-Reactive Alpha-Fetoprotein in Small Hepatocellular Carcinoma: Special Reference to Imaging Diagnosis. Journal of Hepatology, 30, 125-130. https://doi.org/10.1016/S0168-8278(99)80016-6
|
[32]
|
Zhang, Z., Zhang, Y., Wang, Y., et al. (2016) Alpha-Fetoprotein-L3 and Golgi Protein 73 May Serve as Candidate Biomarkers for Diagnosing Alpha-Fetoprotein-Negative Hepatocellular Carcinoma. OncoTargets and Therapy, 9, 123-129. https://doi.org/10.2147/OTT.S90732
|
[33]
|
Cho, E.S. AND Choi, J.Y. (2015) MRI Features of Hepatocellular Carcinoma Related to Biologic Behavior. Korean Journal of Radiology, 16, 449-464. https://doi.org/10.3348/kjr.2015.16.3.449
|
[34]
|
Eguchi, S., Takatsuki, M., Hidaka, M., et al. (2010) Predictor for Histological Microvascular Invasion of Hepatocellular Carcinoma: A Lesson from 229 Consecutive Cases of Curative Liver Resection. World Journal of Surgery, 34, 1034-1038. https://doi.org/10.1007/s00268-010-0424-5
|
[35]
|
胡伟, 马新, 袁亮. 肝细胞癌微血管侵犯与术后复发及预后的相关性[J]. 中国中西医结合外科杂志, 2017, 23(6): 587-590.
|
[36]
|
Liu, Y., Dai, Y., Zhang, X.X., et al. (2018) [Comparative Analysis of Anatomic and Non-Anatomic Hepatectomy for Single Small Hepatocellular Carcinoma with Microvascular Invasion]. Chinese Medical Journal, 98, 1937-1940.
|
[37]
|
Moris, D., Tsilimigras, D.I., Kostakis, I.D., et al. (2018) Anatomic Versus Non-Anatomic Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. European Journal of Surgical Oncology, 44, 927-938. https://doi.org/10.1016/j.ejso.2018.04.018
|
[38]
|
Zhou, Y., Xu, D., Wu, L., et al. (2011) Meta-Analysis of Anatomic Resection versus Nonanatomic Resection for Hepatocellular Carcinoma. Langenbeck’s Archives of Surgery, 396, 1109-1117. https://doi.org/10.1007/s00423-011-0784-9
|
[39]
|
Feng, L.H., Dong, H., Lau, W.Y., et al. (2017) Novel Microvascular Invasion-Based Prognostic Nomograms to Predict Survival Outcomes in Patients after R0 Resection for Hepatocellular Carcinoma. Journal of Cancer Research and Clinical Oncology, 143, 293-303. https://doi.org/10.1007/s00432-016-2286-1
|
[40]
|
Liu, M., Wang, L., Zhu, H., et al. (2016) A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients. Translational Oncology, 9, 167-172. https://doi.org/10.1016/j.tranon.2016.03.002
|
[41]
|
聂彬, 赵铁军, 张胜龙. 肝细胞癌伴微血管侵犯不同切缘方案下根治术的预后分析[J]. 肝脏, 2023, 28(8): 921-923, 964.
|
[42]
|
Yoshida, Y., Kanematsu, T., Matsumata, T., et al. (1989) Surgical Margin and Recurrence after Resection of Hepatocellular Carcinoma in Patients with Cirrhosis. Further Evaluation of Limited Hepatic Resection. Annals of Surgery, 209, 297-301. https://doi.org/10.1097/00000658-198903000-00008
|
[43]
|
Chen, M.S., Li, J.Q., Liang, H.H., et al. (2005) [Comparison of Effects of Percutaneous Radiofrequency Ablation and Surgical Resection on Small Hepatocellular Carcinoma]. Chinese Medical Journal, 85, 80-83.
|
[44]
|
Huang, J., Yan, L., Cheng, Z., et al. (2010) A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria. Annals of Surgery, 252, 903-912. https://doi.org/10.1097/SLA.0b013e3181efc656
|
[45]
|
Lü, M.D., Kuang, M., Liang, L.J., et al. (2006) [Surgical Resection versus Percutaneous Thermal Ablation for Early-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial]. Chinese Medical Journal, 86, 801-805.
|
[46]
|
Minami, Y., Minami, T., Hagiwara, S., et al. (2018) Ultrasound-Ultrasound Image Overlay Fusion Improves Real-Time Control of Radiofrequency Ablation Margin in the Treatment of Hepatocellular Carcinoma. European Radiology, 28, 1986-1993. https://doi.org/10.1007/s00330-017-5162-8
|
[47]
|
Llovet, J.M. and Bruix, J. (2003) Systematic Review of Randomized Trials for Unresectable Hepatocellular Carcinoma: Chemoembolization Improves Survival. Hepatology, 37, 429-442. https://doi.org/10.1053/jhep.2003.50047
|
[48]
|
Chen, Z.H., Zhang, X.P., Zhou, T.F., et al. (2019) Adjuvant Transarterial Chemoembolization Improves Survival Outcomes in Hepatocellular Carcinoma with Microvascular Invasion: A Systematic Review and Meta-Analysis. European Journal of Surgical Oncology, 45, 2188-2196. https://doi.org/10.1016/j.ejso.2019.06.031
|
[49]
|
Lau, W.Y., Lai, E.C.H., Leung, T.W.T., et al. (2008) Adjuvant Intra-Arterial Iodine-131-Labeled Lipiodol for Resectable Hepatocellular Carcinoma: A Prospective Randomized Trial-Update on 5-Year and 10-Year Survival. Annals of Surgery, 247, 43-48. https://doi.org/10.1097/SLA.0b013e3181571047
|
[50]
|
Cheng, X., Sun, P., Hu, Q.G., et al. (2014) Transarterial (Chemo) Embolization for Curative Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analyses. Journal of Cancer Research and Clinical Oncology, 140, 1159-1170. https://doi.org/10.1007/s00432-014-1677-4
|
[51]
|
Wang, L., Ke, Q., Lin, N., et al. (2019) Does Postoperative Adjuvant Transarterial Chemoembolization Benefit for All Patients with Hepatocellular Carcinoma Combined with Microvascular Invasion: A Meta-Analysis. Scandinavian Journal of Gastroenterology, 54, 528-537. https://doi.org/10.1080/00365521.2019.1610794
|
[52]
|
Agopian, V.G., Harlander-Locke, M., Zarrinpar, A., et al. (2015) A Novel Prognostic Nomogram Accurately Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Analysis of 865 Consecutive Liver Transplant Recipients. Journal of the American College of Surgeons, 220, 416-427. https://doi.org/10.1016/j.jamcollsurg.2014.12.025
|
[53]
|
Liu, L., Cao, Y., Chen, C., et al. (2006) Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5. Cancer Research, 66, 11851-11858. https://doi.org/10.1158/0008-5472.CAN-06-1377
|
[54]
|
Kudo, M., Finn, R.S., Qin, S., et al. (2018) Lenvatinib Versus Sorafenib in First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Randomised Phase 3 Non-Inferiority Trial. The Lancet, 391, 1163-1173. https://doi.org/10.1016/S0140-6736(18)30207-1
|